10 free Series 79 practice questions in the real exam format, covering the official content areas, with an explanation for every answer.
Series 79 Practice Test 10Tutor mode
Question 1 of 10
Collection, Analysis and Evaluation of Data
Delmar Therapeutics reported a net loss of $40 million for the year. It has 10 million in-the-money stock options and a convertible note outstanding. How are these securities treated in its diluted EPS?